Exicure
E645747
Exicure is a biotechnology company focused on developing nucleic acid therapeutics using its proprietary spherical nucleic acid (SNA) technology platform.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Exicure canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T7156988 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Exicure Context triple: [Exicure, Inc., abbreviation, Exicure]
-
A.
Scorpiace
Scorpiace is an early Christian apologetic treatise by Tertullian that defends the value of martyrdom against heretical teachings.
-
B.
Exody
Exody is a large-scale orchestral composition by British contemporary composer Harrison Birtwistle, noted for its complex textures and dramatic, ritualistic atmosphere.
-
C.
Scorcha
Scorcha is a dancehall and reggae fusion album by Jamaican artist Sean Paul, showcasing his signature upbeat, club-ready sound.
-
D.
D’Evils
"D’Evils" is a dark, introspective track by Jay-Z from his debut album "Reasonable Doubt," exploring the moral conflicts and corrupting influence of street life and the pursuit of wealth.
-
E.
Furiani
Furiani is a commune on the French Mediterranean island of Corsica, known for its proximity to Bastia and its coastal setting.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Exicure Target entity description: Exicure is a biotechnology company focused on developing nucleic acid therapeutics using its proprietary spherical nucleic acid (SNA) technology platform.
-
A.
Scorpiace
Scorpiace is an early Christian apologetic treatise by Tertullian that defends the value of martyrdom against heretical teachings.
-
B.
Exody
Exody is a large-scale orchestral composition by British contemporary composer Harrison Birtwistle, noted for its complex textures and dramatic, ritualistic atmosphere.
-
C.
Scorcha
Scorcha is a dancehall and reggae fusion album by Jamaican artist Sean Paul, showcasing his signature upbeat, club-ready sound.
-
D.
D’Evils
"D’Evils" is a dark, introspective track by Jay-Z from his debut album "Reasonable Doubt," exploring the moral conflicts and corrupting influence of street life and the pursuit of wealth.
-
E.
Furiani
Furiani is a commune on the French Mediterranean island of Corsica, known for its proximity to Bastia and its coastal setting.
- F. None of above. chosen
Statements (40)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
public company ⓘ |
| aimsTo |
expand therapeutic applications of nucleic acids
ⓘ
improve delivery of nucleic acid drugs ⓘ |
| basedOnResearchOf | Chad Mirkin NERFINISHED ⓘ |
| develops |
therapeutics for genetic disorders
ⓘ
therapeutics for immuno-oncology ⓘ therapeutics for neurology ⓘ |
| focusesOn | nucleic acid therapeutics ⓘ |
| foundedBy | Chad Mirkin NERFINISHED ⓘ |
| foundedIn | 2011 ⓘ |
| hasBusinessModel |
drug discovery and development
ⓘ
strategic collaborations with larger pharmaceutical companies ⓘ |
| hasCollaboration |
Allergan (now part of AbbVie)
NERFINISHED
ⓘ
Ipsen NERFINISHED ⓘ |
| hasIntellectualProperty |
patents on SNA-based therapeutics
ⓘ
patents on spherical nucleic acid constructs ⓘ |
| hasPipeline |
clinical-stage SNA-based therapeutics
ⓘ
preclinical SNA-based therapeutics ⓘ |
| hasTechnologyPlatform | spherical nucleic acid (SNA) platform ⓘ |
| headquarteredIn | United States NERFINISHED ⓘ |
| industry | biotechnology ⓘ |
| listedOn | NASDAQ ⓘ |
| originatesFrom | Northwestern University nanotechnology research ⓘ |
| researchArea |
dermatology applications of nucleic acids
ⓘ
neurological disease applications of nucleic acids ⓘ oncology applications of nucleic acids ⓘ |
| specializesIn | spherical nucleic acid drug design ⓘ |
| technologyFeature |
dense nucleic acid shell on nanoparticle core
ⓘ
enhanced cellular uptake ⓘ improved stability of nucleic acids ⓘ potential for targeted delivery ⓘ |
| tickerSymbol | XCUR NERFINISHED ⓘ |
| usesAbbreviation | SNA NERFINISHED ⓘ |
| usesApproach |
nanoparticle-based nucleic acid delivery
ⓘ
topical and local administration of nucleic acids ⓘ |
| usesModality |
antisense oligonucleotides
ⓘ
oligonucleotide therapeutics ⓘ siRNA therapeutics ⓘ |
| usesTechnology | spherical nucleic acid technology ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Exicure Description of subject: Exicure is a biotechnology company focused on developing nucleic acid therapeutics using its proprietary spherical nucleic acid (SNA) technology platform.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.